NSECertificate under SEBI (Depositories and Participants) Regulations, 20189 Jul 2026 · 9 Jul 2026, 03:56 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Bafna Pharmaceuticals Limited · BAFNAPH

✦ AI Summary

Bafna Pharmaceuticals Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, confirming the dematerialization of securities and listing on stock exchanges.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.

Attachments (1)

📄

BAFNAPH_09072026155557_REGULATION_74_5_.pdf

pdf

Download →
View document text
BAFNA PHARMACEUTICALS LIMITED REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com CIN: L24294TN1995PLCO30698 Date: July 09, 2026 BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Mumbai - 400001. Bandra East, Mumbai – 400051. Scrip Code: 532989 Scrip Code: BAFNAPH Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories And Participants) Regulations, 2018 for the Quarter ended June 30, 2026 Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a copy of the Certificate received from M/s. Cameo Corporate Services Limited, the Registrar and Share Transfer Agent (RTA) of the Company, for the Quarter ended June 30, 2026. We request you to take the document on record. Thanking You. For BAFNA PHARMACEUTICALS LIMITED Mohanachandran A Company Secretary & Compliance Officer Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com CAMEO CORPORATE SERVICES LIMITED Ref: CAM/BPR/74(5)/2026 6th July, 2026 THE COMPANY SECRETARY M/S. BAFNA PHARMACEUTICALS LIMITED BAFNA TOWERS NO 299 THAMBU CHETTY STREET CHENNAI TAMILNADU 600001 Dear Sir, Subject: Certificate under of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2026. ------ With reference to the above captioned subject, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 30th June 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as the registered owner within stipulated time limit under captioned regulations. Thanking you Yours faithfully For CAMEO CORPORATE SERVICES LIMITED ASST. MANAGER (SHARES) CIN No:U67120TN1998PLC041613 'Subramanian Building', No.1, Club House Road, Chennai-600 002. Phone: (D) 044-40020710 / 044-2846 0390, Fax: 044-2846 0129 E-mail: cameo@cameoindia.com Website: www.cameoindia.com